Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Modern Rheumatology|January 25, 2021
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry studyMochihito Suzuki, Toshihisa Kojima, Nobunori Takahashi, et al.
Clinical Rheumatology|December 4, 2015
Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patientsToshihisa Kojima, Nobunori Takahashi, Atsushi Kaneko, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Improvement in matrix metalloproteinase-3 independently predicts low disease activity at 52 weeks in bio-switch rheumatoid arthritis patients treated with abataceptToki Takemoto, Nobunori Takahashi, Daihei Kida, et al.
Clinical Rheumatology|February 6, 2016
Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort studyToshihisa Kojima, Nobunori Takahashi, Koji Funahashi, et al.
The Journal of Rheumatology|July 17, 2014
Longterm retention rate and risk factor for discontinuation due to insufficient efficacy and adverse events in Japanese patients with rheumatoid arthritis receiving etanercept therapyHiroyuki Matsubara, Toshihisa Kojima, Atsushi Kaneko, et al.
Modern Rheumatology|September 15, 2012
Clinical efficacy of abatacept in Japanese rheumatoid arthritis patientsNobunori Takahashi, Toshihisa Kojima, Kenya Terabe, et al.
Clinical Rheumatology|September 24, 2013
Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activityNobunori Takahashi, Toshihisa Kojima, Atsushi Kaneko, et al.
Rheumatology International|May 21, 2015
Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD useNobunori Takahashi, Takayoshi Fujibayashi, Daihei Kida, et al.
Scientific Reports|November 13, 2020
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patientsDaihei Kida, Nobunori Takahashi, Atsushi Kaneko, et al.
Modern Rheumatology|March 16, 2024
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)Shuji Asai, Mochihito Suzuki, Ryota Hara, et al.
Pageof 10